Teva Pharmaceuticals Submits New Drug Application to FDA for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

Olanzapine long-acting injectable (LAI) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation, for a ...
eLife

The Fd4 transcription factor translates transient spatial cues in progenitors into long-term lineage identity

Institute of Neuroscience, Howard Hughes Medical Institute, University of Oregon, Eugene, United States ...

NetApp, Inc. (NTAP) Presents at Raymond James TMT & Consumer Conference Transcript

Raymond James TMT & Consumer Conference December 9, 2025 11:20 AM ESTCompany ParticipantsJeriel OngConference Call ...
AlphaGalileo

NUS scientists create microneedle system to deliver biofertiliser directly into plants, boosting growth with less waste

Researchers at the National University of Singapore (NUS) have developed dissolving microneedle patches that deliver living ...